Open Access

The value of NT-proBNP in cardiovascular risk stratification and optimization of cardioprotective treatment among patients with type 2 diabetes.

logo

Topic: Biomarkers
Sponsored by Roche Diagnostics International

Congress Presentation

About the speaker

Doctor Muthiah Vaduganathan

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
9 presentations
2 followers

4 more presentations in this session

Introduction.

Speaker: Doctor D. Gualandro (Basel, CH)

Thumbnail

The value of high-sensitivity troponin T in patients undergoing noncardiac surgery.

Speaker: Doctor C. Puelacher (Basel, CH)

Thumbnail

Using NT-proBNP to screen patients with afib: results from the STROKESTOP II trial.

Speaker: Doctor K. Kemp Gudmundsdottir (Stockholm, SE)

Thumbnail

Access the full session

Cardiac biomarkers are here to stay

Speakers: Doctor M. Vaduganathan, Doctor D. Gualandro, Doctor C. Puelacher, Doctor K. Kemp Gudmundsdottir
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACNAP Premium Access

Shared decision making: how to do it practically

23 May 2022

EHRA Premium Access

EAST- AFNET 4 in clinical practice.

3 April 2022

ACVC Premium Access

Clinical trial evidence.

18 March 2022

ESC 365 is supported by

logo Novo Nordisk